What is Camson Bio Technologies Ltd (538858) share price return in the past 10 years?

Camson Bio Technologies Ltd share price has declined -16% annually (CAGR) over the past ten years.

What is the share price of Camson Bio Technologies Ltd (538858)?

Company share prices are keep on changing according to the market conditions. The current trading price of Camson Bio Technologies Ltd (538858) on 11-May-2020 18:01:19 at 18:01 is 3.31.

What is the P/E ratio of Camson Bio Technologies?

The latest standalone P/E ratio of Camson Bio Technologies as of 11-May-2020 is 0.00.

What is the P/B ratio of Camson Bio Technologies Ltd (538858)?

The latest standalone P/B ratio of Camson Bio Technologies Ltd (538858) as of 11-May-2020 is 0.27.

What is the 52-week high and low of Camson Bio Technologies Ltd (538858)?

The 52-week high of Camson Bio Technologies Ltd (538858) is Rs. 3.31 and the 52-week low is Rs. 3.31.

Camson Bio Technologies Ltd (538858) Share Analysis – Quality, Growth & Valuation Zone & DeciZen Rating

Name: Camson Bio Technologies Ltd (538858)
Brand: Camson Bio Technologies

Camson Bio Technologies Ltd (538858)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 538858 NSE: Agriculture | Small Cap | Camson Bio Share Price

Camson Bio Technologies Ltd (538858)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 538858 NSE: Agriculture | Small Cap | Camson Bio Share Price

Key Metrics

Valuation Multiples

Market Cap

₹10 Cr.

Current Price

₹3.3

52-Week Low / High

₹3 / 3

TTM EPS

₹-8.4

TTM Sales

₹4.9 Cr.

Book Value per Share

₹12.4

P/E Ratio

0.00

Industry PE

15.5

Price to Book (P/B)

0.27

Price to Sales (P/S)

2.04

EV/EBITDA

-4.53

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-39.31%

Return on Capital Employed (ROCE)

-19.21%

Return on Assets (ROA)

-16.76%

Operating Profit Margin

-329.4%

Net Profit Margin

-440.02%

Gross Profit Margin

-288%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-74.21%

Operating Profit Growth (1 Year)

-54733.33%

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

24.46%

Pledged shares (%) of Promoter's holding (%)

26.49%

Reserves

₹7 Cr.

Equity

₹30 Cr.

Face Value

₹10

All Time Low / High

₹3.31 / 252.00

Camson Bio Technologies stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	25.4%	24.4%	16.9%	14.8%	7.1%	4.1%	-15.5%	-12.2%	-4.9%	-19.2%	-
Value Creation Index ⓘ	0.8	0.7	0.2	0.1	-0.5	-0.7	-2.1	-1.9	-1.4	-2.4	-
Growth Parameters ⓘ
Sales ⓘ	80	98.7	112	120	146	169	25.4	10.4	19.3	5	5
Sales YoY Gr.	-	23.5%	13.7%	6.6%	21.8%	16.3%	-85%	-59.3%	86.6%	-74.2%	-
Adj EPS ⓘ	8.5	12.1	11.4	12.7	6.3	1	-12.6	-7.7	-3.7	-7.3	-8.4
YoY Gr.	-	42.7%	-5.9%	11%	-50.8%	-83.7%	-1336.3%	NA	NA	NA	-
BVPS (₹) ⓘ	43.2	57.9	69.3	80.8	80.8	88	34.8	25.7	22.2	14.9	12.4
Adj Net Profit ⓘ	13.7	22	20.7	23	15.8	3.1	-37.8	-23.2	-11.2	-21.9	-25
Cash Flow from Ops. ⓘ	10.5	-1.9	10.2	-13.5	-14.7	14.1	-10	4.6	1.8	0	-
Debt/CF from Ops. ⓘ	0.1	-0.6	1.2	-3	-2.7	2.6	-4.7	10.1	26.7	554260.7	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-26.5%	-49.1%	-41.9%	-74.2%
Adj EPS ⓘ	-198.3%	-203.2%	NA	NA
BVPSⓘ	-11.2%	-28.7%	-24.6%	-32.9%
Share Price	-16%	-	-	-

Key Financial Parameters ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	23.7	24.1	17.8	16	8.1	1.3	-20.5	-25.6	-15.6	-39.3	-61.4
Op. Profit Mgn % ⓘ	20.3	22.8	19.6	23.6	17	10.9	-56.6	-127.7	0.2	-329.4	-439.3
Net Profit Mgn % ⓘ	17.1	22.3	18.5	19.2	10.8	1.8	-148.9	-224.1	-58.2	-440	-516.8
Debt to Equity ⓘ	0	0	0.1	0.3	0.2	0.1	0.5	0.6	0.7	1.1	-
Working Cap Days ⓘ	142	226	297	354	385	382	1,745	1,871	899	3,057	1,678
Cash Conv. Cycle ⓘ	125	188	237	270	275	299	1,356	606	483	2,737	-1,110

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Sales	79.98	98.74	112.24	119.61	145.63	169.38	25.40	10.35	19.31	4.98
Operating Expenses ⓘ +	63.76	76.23	90.29	91.44	120.95	150.84	39.78	23.56	19.28	21.37
Manufacturing Costs	16.42	58.15	40.51	44.99	23.93	36.51	5.35	1.62	0.58	0.33
Material Costs	14.43	-18.81	4.24	12.43	48.64	48.97	4.84	2.48	7.70	15.18
Employee Cost	2.09	4.40	5.08	7.07	8.57	12.94	9.92	5.95	4.21	2.11
Other Costs ⓘ	30.82	32.49	40.46	26.95	39.81	52.43	19.67	13.52	6.79	3.74
Operating Profit ⓘ	16.22	22.51	21.95	28.17	24.68	18.54	-14.38	-13.21	0.03	-16.39
Operating Profit Margin (%)	20.3%	22.8%	19.6%	23.6%	16.9%	10.9%	-56.6%	-127.0%	0.2%	-329.0%
Other Income ⓘ +	0.35	0.94	0.49	0.30	0.53	6.35	1.16	3.94	1.30	3.20
Exceptional Items ⓘ	0	0	0	0	-3.56	0	0	0	0	0
Interest ⓘ	0.20	0.14	0.36	2.01	3.87	4.09	4.99	6.51	5.36	1.14
Depreciation ⓘ	1.66	0.92	1.64	3.35	5.11	13.40	21.72	7.44	7.19	6.97
Profit Before Tax ⓘ	14.71	22.39	20.45	23.11	12.67	7.40	-39.93	-23.22	-11.22	-21.31
Tax ⓘ	1.06	0.38	-0.28	0.10	-0.60	4.32	-2.09	-0.17	0	0.59
Profit After Tax	13.66	22.01	20.72	23.01	13.27	3.08	-37.83	-23.05	-11.22	-21.90
PAT Margin (%)	17.1%	22.3%	18.5%	19.2%	9.1%	1.8%	-148.0%	-222.0%	-58.1%	-440.0%
Adjusted EPS (₹)	8.5	12.1	11.4	12.7	5.3	1.0	-12.6	-7.7	-3.7	-7.3
Dividend Payout Ratio (%)	11.80%	8.20%	8.80%	7.90%	19%	0%	0%	0%	0%	0%

Valuation of Camson Bio - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund +	69.37	104.88	125.59	146.50	203.86	263.98	104.24	77.03	66.66	44.75
Share Capital ⓘ	16.05	18.13	18.13	18.13	25.23	30	30	30	30	30
Reserves ⓘ	53.32	86.75	107.46	128.37	178.63	233.98	74.24	47.03	36.66	14.75
Debt +	1	0.99	12.39	38.42	37.07	36.64	46.69	45.87	48.70	49.82
Long Term Debt	1	0.19	2.53	15.91	11.95	4.94	9.49	8.42	9.81	11.38
Short Term Debt	0	0.80	9.86	22.51	25.12	31.70	37.20	37.45	38.88	38.44
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.41	13.81	7.50	2.76	3.52	10.37	6.86	7.51	8.28	7.62
Others Liabilities ⓘ	14.70	11.56	7.68	28.90	37.81	12.65	13	15.51	16.72	18.74
Total Liabilities ⓘ	85.49	131.25	153.17	216.58	282.26	323.65	170.79	145.92	140.36	120.92
Fixed Assets
Net Fixed Assets ⓘ +	28.87	26.61	34.63	78.42	109.60	138.55	116.83	106.29	100.19	93.22
Gross Block	35.48	31.26	40.92	88.06	124.32	166.51	151.41	147.89	148.98	148.98
Accumulated Depreciation	6.61	4.65	6.29	9.64	14.72	27.96	34.57	41.60	48.79	55.76
CWIP ⓘ	5.52	11.16	22.12	0	0.01	0	0	0	0	0
Investments ⓘ	0.84	4.35	0.01	0.01	0.01	0.01	5.98	3.40	3.40	3.40
Inventories	22.30	42.72	40.01	39.56	39.98	25.34	9.24	11.92	40.35	25.88
Trade Receivables	11.73	42.36	46.93	64.06	84.01	145.49	16.60	3.72	5.11	6.57
Cash Equivalents	15.03	1.94	0.86	1.68	1.92	1.03	0.30	0.23	0.09	0.06
Others Assets ⓘ	1.19	2.10	8.61	32.85	46.73	13.24	21.84	20.36	-8.78	-8.21
Total Assets ⓘ	85.49	131.25	153.17	216.58	282.26	323.65	170.79	145.92	140.36	120.92

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ +	10.45	-1.85	10.15	-13.48	-14.67	14.12	-9.99	4.56	1.83	0
PBT ⓘ	16.21	22.39	20.45	23.11	12.67	5.05	-39.93	-27.37	-11.05	-21.90
Adjustment ⓘ	0.52	0.87	1.76	8.71	17.22	23.56	26.37	22.15	11.59	4.93
Changes in Working Capital ⓘ	-6.23	-24.73	-12.06	-45.29	-45.14	-14.99	4.2	9.84	1.28	16.96
Tax Paid ⓘ	-0.05	-0.38	0	0	0.58	0.50	-0.63	-0.05	0	0
Cash Flow From Investing Activity ⓘ +	-18.56	-20.83	-20.18	-25.02	-36.31	-43.31	5.29	2.72	0.73	-0.01
Capex	-17.93	-17.49	-20.62	-25.02	-36.32	-43.32	11.21	2.69	-0.41	-0.01
Net Investments	-0.83	-3.51	0	0	0	0	-5.97	0	0	0
Others ⓘ	0.20	0.17	0.44	0	0	0.01	0.05	0.03	1.15	0
Cash Flow From Financing Activity ⓘ +	21.99	9.60	8.95	39.32	51.23	28.30	4.23	-7.33	-2.53	-0.02
Net Proceeds from Shares ⓘ	17.63	15.60	0	0	44.14	31.89	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0.03	-0.02	-0.36	-1.80	-3.31	-3.96	-4.99	-6.51	-5.36	-1.14
Dividend Paid ⓘ	-1.60	-1.87	0	-2.10	-2.12	0	0	0	0	0
Others ⓘ	6	-4.11	9.31	43.22	12.52	0.37	9.22	-0.82	2.83	1.12
Net Cash Flow ⓘ	13.88	-13.09	-1.08	0.82	0.24	-0.89	-0.47	-0.04	0.03	-0.03

Financial Ratio

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	24.97	25.26	17.98	16.91	7.58	1.32	-20.55	-25.44	-15.61	-39.31
ROCE (%)	25.36	24.42	16.91	14.77	7.06	4.05	-15.45	-12.18	-4.92	-19.21
Asset Turnover Ratio	1.21	0.91	0.79	0.65	0.58	0.56	0.1	0.07	0.13	0.04
PAT to CFO Conversion(x)	0.77	-0.08	0.49	-0.59	-1.11	4.58	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	43.50	100	145.20	169.40	185.60	247.30	1,164.40	358.20	83.40	428.60
Inventory Days	85	120.20	134.50	121.40	99.70	70.40	248.40	373	494	2,429.10
Payable Days	17.60	-138	918.40	150.70	23.60	51.80	649.80	1,059.70	374.30	191.20

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

26.49

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Camson Bio Technologies Ltd FAQs

The current trading price of Camson Bio on 11-May-2020 18:01 is ₹3.31.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-May-2020 the market cap of Camson Bio stood at ₹9.93 Cr

The latest P/E ratio of Camson Bio as of 10-May-2020 is 0.00.

The latest P/B ratio of Camson Bio as of 10-May-2020 is 0.27.

The 52-week high of Camson Bio is ₹3.31 and the 52-week low is ₹3.31.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Camson Bio is ₹4.87 ( Cr.) .

Data is not available for this company.

The key valuation ratios of Camson Bio Technologies Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Camson Bio Technologies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Camson Bio Technologies Ltd

Camson, incorporated in 1993 is India's first wholly integrated Agriculture Biotechnology, is based at Bangalore, garden city of India. It became a Public Company in 1995. Camson has been promoted by technocrats with vast relevant experience. Its Vision is to create a healthy and disease free society by providing safe food. This vision forms the guiding beacon of Camson in its pursuit for wholesome goodness in agriculture and aims at being world class manufacture of Biotechnology products

The Company has a strong presence in the Indian market and has unique research and intellectual proprietary which gives the Company an edge over others. Its proprietary technology platform consists of microorganism database, superior proprietary seeds germplasm, screening technology, biocides, biofertilisers and hybrid seeds.

Camson has developed many unique biocides for plant protection and hybrid seeds for improved productivity. Their superior technology in crop transformation and functional genomics has helped in developing new products which are first of its kind in the country.

The infrastructure set up of the Company is at Bangalore North. The set up provides for a total composite production. It is State-of-the-art and spread over 20 acres of land. This affords a high level of space for multi-product production, simultaneously. The Company constantly upgrades its production facilities to keep pace with the increased demand for its products as also for producing a wider range of products pursuant to the success achieved on its research front.

Product range of the company includes:

Bio Fungicides
Bio Insecticides
Bio Stimulants
Bio Fertilisers
Hybrid Seeds

Achievements/ recognition:

Camson Bio Technologies has been recognized, for the second year in succession, as one of the fastest growing technology companies and placed at 17th position, in the Technology 50 India 2008 programme conducted by Deloitte Touche Tohmatsu, Asia Pacific.
Camson was declared a Stellar performer for the second year in a row under Technology Fast 500 Asia Pacific Ranking and CEO Survey 2008, obtaining 131st rank out of 500 companies identified by Deloitte.

Camson Bio Technologies Ltd (538858)

Camson Bio Technologies Ltd (538858)

Camson Bio Technologies stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Camson Bio - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Camson Bio Technologies Ltd FAQs

About Camson Bio Technologies Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Camson Bio Technologies Ltd (538858)

Camson Bio Technologies Ltd (538858)

Camson Bio Technologies stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Camson Bio - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Camson Bio Technologies Ltd FAQs

What is the share price of Camson Bio?

What is the market cap of Camson Bio?

What is the P/E ratio of Camson Bio?

What is the P/B ratio of Camson Bio?

What is the 52-week high and low of Camson Bio?

What is the TTM revenue of Camson Bio?

Is Camson Bio Technologies Ltd. a good quality company?

Is Camson Bio Technologies Ltd. undervalued or overvalued?

Is Camson Bio Technologies Ltd. a good buy now?

About Camson Bio Technologies Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.